---
title: CDMO Daily News — June 24, 2026
slug: daily-news-2026-06-24-cdmo
site: cdmo
post_kind: news
byline: BioBM
last_updated: 2026-06-24T00:00:30.113Z
---

### EMA Convenes AI in GMP Workshop to Shape Annex 22 Guidance on Adaptive Models
- EMA hosts two-day multistakeholder workshop (30 June–1 July 2026) to gather expert input on responsible AI use in medicines manufacturing under proposed Annex 22 guidance.
- Workshop focuses on control measures, guardrails, and risk-based approaches for generative AI and large language models in critical GMP applications previously flagged as prohibited.
- EMA seeks expert consensus on validation paradigms, human oversight requirements, and safeguards against hallucinations and model drift in high-risk manufacturing workflows.

**Operational Impact**

CDMOs and manufacturers must prepare for evolving EMA expectations on AI governance in GMP; the workshop outcomes will inform final Annex 22 rules that may enable or constrain adoption of adaptive and generative AI in critical manufacturing processes.

*Source: [EMA What's New RSS](https://www.ema.europa.eu/en/events/good-manufacturing-practice-multistakeholder-workshop-expert-contributions-artificial-intelligence-guidance-development-annex-22)*

## References

1. [EMA What's New RSS — EMA Convenes AI in GMP Workshop to Shape Annex 22 Guidance on Adaptive Models](https://www.ema.europa.eu/en/events/good-manufacturing-practice-multistakeholder-workshop-expert-contributions-artificial-intelligence-guidance-development-annex-22)

Source: https://cdmo.directory/posts/daily-news-2026-06-24-cdmo